InsiderClue
Stocks · Health care · Medicinal Chemicals & Botanical Products

Niagen Bioscience, Inc.

NAGE Clue Score76
United States Fiscal year ends December CIK 0001386570
$2.69 +1.13% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.69 −58.68% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−2.9Net income−2.9Fiscal year 2017Revenue21.2Operating income−16.4Net income−11.4Fiscal year 2018Revenue31.6 +48.8%Operating income−33.2Net income−33.3Fiscal year 2019Revenue46.3 +46.7%Operating income−31.3Net income−32.1Fiscal year 2020Revenue59.3 +28.0%Operating income−19.9Net income−19.9EPS, diluted−0.33Fiscal year 2021Revenue67.4 +13.8%Operating income−27.1Net income−27.1EPS, diluted−0.40Fiscal year 2022Revenue72.1 +6.8%Operating income−18.6Net income−16.5EPS, diluted−0.24Fiscal year 2023Revenue83.6 +16.0%Operating income−5.6Net income−4.9EPS, diluted−0.07Fiscal year 2024Revenue99.6 +19.2%Operating income7.7Net income8.6EPS, diluted0.11Fiscal year 2025Revenue129.4 +29.9%Operating income16.3Net income17.4 +103.3%EPS, diluted0.20 +81.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 21.2 31.6 46.3 59.3 67.4 72.1 83.6 99.6 129.4
Growth +48.8% +46.7% +28.0% +13.8% +6.8% +16.0% +19.2% +29.9%
Operating income −2.9 −16.4 −33.2 −31.3 −19.9 −27.1 −18.6 −5.6 7.7 16.3
Net income −2.9 −11.4 −33.3 −32.1 −19.9 −27.1 −16.5 −4.9 8.6 17.4
Growth +103.3%
EPS, diluted n/a n/a n/a n/a −0.33 −0.40 −0.24 −0.07 0.11 0.20
Growth +81.8%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Fiscal year 2017Gross margin49.4%Operating margin−77.2%Net margin−53.7%Free cash flow margin−51.7%Fiscal year 2018Gross margin50.9%Operating margin−105.1%Net margin−105.6%Free cash flow margin−70.4%Fiscal year 2019Gross margin55.7%Operating margin−67.6%Net margin−69.4%Free cash flow margin−45.8%Fiscal year 2020Gross margin59.5%Operating margin−33.5%Net margin−33.6%Fiscal year 2021Gross margin61.5%Operating margin−40.1%Net margin−40.2%Fiscal year 2022Gross margin59.4%Operating margin−25.9%Net margin−23.0%Fiscal year 2023Gross margin60.8%Operating margin−6.7%Net margin−5.9%Fiscal year 2024Gross margin61.8%Operating margin7.8%Net margin8.6%Fiscal year 2025Gross margin64.3%Operating margin12.6%Net margin13.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a 49.4% 50.9% 55.7% 59.5% 61.5% 59.4% 60.8% 61.8% 64.3%
Operating margin n/a −77.2% −105.1% −67.6% −33.5% −40.1% −25.9% −6.7% 7.8% 12.6%
Net margin n/a −53.7% −105.6% −69.4% −33.6% −40.2% −23.0% −5.9% 8.6% 13.4%
Free cash flow margin n/a −51.7% −70.4% −45.8% n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−2.9Capital expenditure−1.5Free cash flow−4.4Fiscal year 2017Operating cash flow−9.8Capital expenditure−1.2Free cash flow−11.0Buybacks0.0Fiscal year 2018Operating cash flow−20.9Capital expenditure−1.3Free cash flow−22.2Buybacks−0.4Fiscal year 2019Operating cash flow−20.4Capital expenditure−0.7Free cash flow−21.2Fiscal year 2020Operating cash flow−10.6Fiscal year 2021Operating cash flow−24.2Fiscal year 2022Operating cash flow−15.1Fiscal year 2023Operating cash flow7.1Fiscal year 2024Operating cash flow12.1Buybacks0.0Fiscal year 2025Operating cash flow13.5Buybacks−0.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −2.9 −9.8 −20.9 −20.4 −10.6 −24.2 −15.1 7.1 12.1 13.5
Capital expenditure −1.5 −1.2 −1.3 −0.7 n/a n/a n/a n/a n/a n/a
Free cash flow −4.4 −11.0 −22.2 −21.2 n/a n/a n/a n/a n/a n/a
Growth
Buybacks n/a 0.0 −0.4 n/a n/a n/a n/a n/a 0.0 −0.3

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Total debt0.0Shareholders’ equity10.0Debt to equity0.00Fiscal year 2017Shareholders’ equity53.8Fiscal year 2018Cash22.6Shareholders’ equity27.2Fiscal year 2019Cash18.8Shareholders’ equity20.4Fiscal year 2020Cash16.7Shareholders’ equity16.4Fiscal year 2021Cash28.2Shareholders’ equity31.7Fiscal year 2022Cash20.3Shareholders’ equity28.7Fiscal year 2023Cash27.2Shareholders’ equity28.5Fiscal year 2024Cash44.5Shareholders’ equity46.1Fiscal year 2025Cash64.8Shareholders’ equity76.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash n/a n/a 22.6 18.8 16.7 28.2 20.3 27.2 44.5 64.8
Total debt 0.0 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders’ equity 10.0 53.8 27.2 20.4 16.4 31.7 28.7 28.5 46.1 76.5
Debt to equity 0.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 30 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 21.2 31.6 46.3 59.3 67.4 72.1 83.6 99.6 129.4
Growth +48.8% +46.7% +28.0% +13.8% +6.8% +16.0% +19.2% +29.9%
11.3 10.7 15.5 20.5 24.0 26.0 29.3 32.8 38.0 46.2
10.4 10.5 16.1 25.8 35.3 41.5 42.8 50.8 61.6 83.2
Growth +0.8% +53.2% +60.5% +36.9% +17.6% +3.2% +18.7% +21.3% +35.1%
2.5 4.0 5.5 4.4 3.4 3.8 4.8 5.0 6.0 6.3
9.2 17.6 27.1 34.3 30.8 36.4 28.3 25.0 18.4 27.1
−2.9 −16.4 −33.2 −31.3 −19.9 −27.1 −18.6 −5.6 7.7 16.3
Growth +110.7%
−3.6 −16.5 n/a n/a n/a n/a n/a −4.9 8.9 18.2
0.0 0.0 n/a n/a n/a n/a n/a 0.0 0.3 0.8
−2.9 −11.4 −33.3 −32.1 −19.9 −27.1 −16.5 −4.9 8.6 17.4
Growth +103.3%
Per share
n/a n/a n/a n/a −0.33 −0.40 −0.24 −0.07 0.11 0.22
n/a n/a n/a n/a −0.33 −0.40 −0.24 −0.07 0.11 0.20
Growth +81.8%
37.3 n/a n/a n/a 61.1 67.2 69.7 75.0 75.9 79.2
n/a n/a n/a n/a 61.1 67.2 69.7 75.0 78.1 85.4
Growth +10.0% +3.8% +7.5% +4.2% +9.4%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 16.9% a year over five years.
  • The diluted share count rose 39.9% in five years, which is dilution.
  • Operating margin is up 46.1 points on five years ago, at 12.6%.
  • A net loss in 8 of 10 years on file.